Acute diverticulitis in immunosuppressed patients: a 12-year management experience
- PMID: 37079781
- DOI: 10.1111/ans.18370
Acute diverticulitis in immunosuppressed patients: a 12-year management experience
Abstract
Background: Diverticular disease of the colon occurs commonly in developed countries. Immunosuppressed patients are thought to be more at risk of developing acute diverticulitis, worse disease, and higher complications secondary to therapy. This study aimed to assess outcomes for immunosuppressed patients with acute diverticulitis.
Method: A retrospective single-centre review was conducted of all patients presenting with acute diverticulitis at a major tertiary Australian hospital from 2006 to 2018.
Result: A total of 751 patients, comprising of 46 immunosuppressed patients, were included. Immunosuppressed patients were found to be older (62.25 versus 55.96, p = 0.016), have more comorbidities (median Charlson Index 3 versus 1, P < 0.001), and undergo more operative management (13.3% versus 5.1%, P = 0.020). Immunosuppressed patients with paracolic/pelvic abscesses (Modified Hinchey 1b/2) were more likely to undergo surgery (56% versus 24%, P = 0.046), while in patients with uncomplicated diverticulitis, there was no difference in immunosuppressed patients undergoing surgery (6.1% versus 5.1% P = 0.815). Immunosuppressed patients were more likely to have Grade III-IV Clavien-Dindo complication (P < 0.001).
Conclusion: Immunosuppressed patients with uncomplicated diverticulitis can be treated safely with non-operative management. Immunosuppressed patients were more likely to have operative management for Hinchey 1b/II and more likely to have grade III/IV complications.
Keywords: colonic diverticular disease; colonic diverticulitis; elective surgery; emergent surgery; immunosuppression.
© 2023 The Authors. ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.
Similar articles
-
Colonic diverticulitis in chemotherapy patients: should operative indications change? A retrospective cohort study.Int J Surg. 2014 Dec;12(12):1489-94. doi: 10.1016/j.ijsu.2014.10.032. Epub 2014 Nov 7. Int J Surg. 2014. PMID: 25448673 Free PMC article.
-
Medically Treated Diverticular Abscess Associated With High Risk of Recurrence and Disease Complications.Dis Colon Rectum. 2016 Mar;59(3):208-15. doi: 10.1097/DCR.0000000000000533. Dis Colon Rectum. 2016. PMID: 26855395
-
Operative management of colonic diverticular disease in the setting of immunosuppression: A systematic review and meta-analysis.Am J Surg. 2021 Jan;221(1):72-85. doi: 10.1016/j.amjsurg.2020.06.035. Epub 2020 Jul 8. Am J Surg. 2021. PMID: 32814626
-
Surgical management of acute sigmoid diverticulitis.Ann Ital Chir. 2008 Sep-Oct;79(5):311-20. Ann Ital Chir. 2008. PMID: 19149358
-
Systematic review and meta-analysis of the management of acute uncomplicated diverticulitis: time to change traditional practice.Int J Colorectal Dis. 2024 Apr 5;39(1):47. doi: 10.1007/s00384-024-04618-7. Int J Colorectal Dis. 2024. PMID: 38578433 Free PMC article.
Cited by
-
Diverticulitis Management in Complex Medical Contexts.Clin Colon Rectal Surg. 2024 Oct 11;38(4):257-262. doi: 10.1055/s-0044-1791284. eCollection 2025 Jul. Clin Colon Rectal Surg. 2024. PMID: 40501522 Review.
References
-
- Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 2019; 156: 1282-98 e1281.
-
- Serrano Gonzalez J, Lucena de la Poza JL, Garcia R, de Leon L et al. Diverticulitis in immunodeficient patients: our experience in the management of high-risk patients. Rev. Esp. Enferm. Dig. 2020; 112: 47-52.
-
- He S, Lu P, Etzioni D et al. Management of acute diverticulitis in immunocompromised patients-the Mayo Clinic experience. Dis. Colon Rectum. 2023; 66: 434-42.
-
- Brandl A, Kratzer T, Kafka-Ritsch R et al. Diverticulitis in immunosuppressed patients: a fatal outcome requiring a new approach? Can. J. Surg. 2016; 59: 254-61.
-
- McKechnie T, Lee Y, Kruse C et al. Operative management of colonic diverticular disease in the setting of immunosuppression: a systematic review and meta-analysis. Am. J. Surg. 2021; 221: 72-85.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical